Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions
Introduction There is a growing and renewed interest in the use of hallucinogenic drugs in the treatment of psychiatric disorders, especially since the FDA approval of ketamine treatment for resistant depression. The response to hallucinogenic psychedelic substances (ayahuasca, psilocybin, LSD, ket...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cambridge University Press
2022-06-01
|
| Серии: | European Psychiatry |
| Предметы: | |
| Online-ссылка: | https://www.cambridge.org/core/product/identifier/S092493382201820X/type/journal_article |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|